SI
SINT.US SINTX Technologies Inc
- Market cap
- USD 9.22M
- P/E
- -
- P/B
- 2.99x
- ROE
- -280.1%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is SINT.US undervalued?
Graham numberThe Graham number of SINTX Technologies Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
SINTX Technologies Inc fundamental analysis
No fundamental analysis for SINTX Technologies Inc yet.
SINTX Technologies Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About SINTX Technologies Inc
Sintx Technologies, Inc., an advanced ceramics and biomaterials company, engages in the research, development, manufacturing, and commercialization of silicon nitride biomaterials, composites, devices, and related technologies for medical and other applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials…
Full company profileSINTX Technologies Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
SINTX Technologies Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 15.2M | 11.2M | 95.0K | 689K | 594K | 606K | 601K | 2.63M | 1.25M | 1.02M | 4.03M |
| Gross Profit | 11.4M | 4.88M | 39.0K | 138K | 119K | 157K | 336K | 1.84M | 435K | -201K | 2.17M |
| Operating Income | -11.5M | -11.1M | -13.1M | -6.59M | -8.50M | -10.6M | -11.3M | -13.4M | -14.0M | -10.7M | -10.3M |
| EBITDA | -9.60M | -7.38M | -8.19M | -4.32M | -6.53M | -8.63M | -11.1M | -6.60M | -9.61M | -9.65M | -9.06M |
| Net Income | -16.6M | -9.33M | -8.65M | -4.80M | -7.03M | -9.31M | -12.0M | -8.26M | -11.0M | -17.1M | -9.50M |
| EPS | -323 | -9,395 | -2,254 | -308 | -40 | -38 | -38 | -19 | -15 | -6.16 | -1.42 |
| Balance Sheet | |||||||||||
| Total Assets | 26.3M | 14.6M | 11.5M | 9.15M | 30.4M | 21.8M | 15.8M | 15.4M | 9.41M | 9.51M | 8.90M |
| Total Liabilities | 11.9M | 9.20M | 3.12M | 3.95M | 4.64M | 4.65M | 10.1M | 6.59M | 5.52M | 6.58M | 5.51M |
| Shareholders' Equity | 14.4M | 5.44M | 8.40M | 5.20M | 25.8M | 17.2M | 5.70M | 8.77M | 3.89M | 2.93M | 3.39M |
| Cash & Short-term Investments | 6.92M | 539K | 5.45M | 1.79M | 25.4M | 14.3M | 6.25M | 3.34M | 3.60M | 4.14M | 2.01M |
| Total Debt | 7.01M | 2.96M | - | 2.25M | 2.28M | 2.91M | 3.63M | 4.76M | 4.03M | 3.25M | 3.00M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -7.17M | -4.68M | -9.35M | -6.44M | -9.11M | -10.1M | -10.3M | -14.1M | -8.64M | -8.57M | -8.84M |
| Capital Expenditure | 671K | 1.19M | 61.0K | 147K | 360K | 3.74M | 1.41M | 530K | 690K | 189K | 313K |
| Free Cash Flow | -7.84M | -5.87M | -9.41M | -6.58M | -9.47M | -13.9M | -11.7M | -14.6M | -9.33M | -8.76M | -9.15M |
| Ratios | |||||||||||
| ROE | -115.5% | -171.4% | -103.0% | -92.2% | -27.2% | -54.1% | -211.1% | -94.2% | -283.1% | -583.2% | -280.1% |
| ROA | -63.2% | -63.7% | -75.1% | -52.4% | -23.1% | -42.6% | -76.3% | -53.8% | -117.1% | -179.7% | -106.7% |
| Net Profit Margin | -109.0% | -83.1% | -9,107.4% | -696.2% | -1,183.3% | -1,536.1% | -2,003.2% | -314.4% | -884.8% | -1,678.1% | -235.7% |
| Debt to Equity | 0.49x | 0.54x | - | 0.43x | 0.09x | 0.17x | 0.64x | 0.54x | 1.03x | 1.11x | 0.89x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
SINTX Technologies Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | USD 6.53M | 15 | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | USD 157K | 10 | - |
| 2018 | - | - | - |
| 2017 | USD 6.28M | 6,322 | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:200 on May 28, 2024.
Who owns SINTX Technologies Inc
- Insiders 26.92%
- Institutions 12.68%
- Public & others 60.40%
- Shares outstanding 7.56M
- Free float 6.03M
Top funds holding SINT.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Fidelity Extended Market Index | 16.7K | 0.22% | 0.00% | Sep 2026 |
| Fidelity Series Total Market Index | 4.29K | 0.06% | 0.00% | Sep 2026 |
| Fidelity Total Market Index | 1.86K | 0.02% | 0.00% | Sep 2026 |
Top institutions holding SINT.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Bleichroeder LP | 523K | 7.85% | 0.00% | Jun 2026 |
| Stonepine Capital Management Llc | 209K | 3.14% | 0.00% | Jun 2026 |
| Veracity Capital LLC | 76.7K | 1.15% | 0.00% | Jun 2026 |
| Citadel Advisors Llc | 31.9K | 0.48% | 0.00% | Jun 2026 |
| Geode Capital Management, LLC | 30.1K | 0.45% | -6.36% | Jun 2026 |
| Vanguard Fiduciary Trust Co | 23.5K | 0.35% | 0.00% | Jun 2026 |
| Vanguard Capital Management, LLC | 20.9K | 0.31% | 0.00% | Jun 2026 |
| State Street Corp | 13.3K | 0.20% | 0.00% | Jun 2026 |
| HRT FINANCIAL LLC | 12.8K | 0.19% | 0.00% | Jun 2026 |
| UBS Group AG | 11.9K | 0.18% | +140.68% | Jun 2026 |
| Virtus Wealth Solutions LLC | 10.0K | 0.15% | 0.00% | Jun 2026 |
| Tower Research Capital LLC | 2.85K | 0.04% | +144.22% | Jun 2026 |
| SignatureFD, LLC | 1.72K | 0.03% | +49.96% | Jun 2026 |
| Royal Bank of Canada | 39.00 | 0.00% | 0.00% | Jun 2026 |
| SBI Securities Co Ltd | 14.00 | 0.00% | 0.00% | Jun 2026 |
| Hanson Mcclain Inc | 1.00 | 0.00% | 0.00% | Jun 2026 |
| NATIONAL BANK OF CANADA /FI/ | 1.00 | 0.00% | 0.00% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 1.00 | 0.00% | -94.44% | Jun 2026 |
| Cornerstone Planning Group LLC | 1.00 | 0.00% | 0.00% | Jun 2026 |
| Advisor Group Holdings, Inc. | 1.00 | 0.00% | -50.00% | Jun 2026 |
SINTX Technologies Inc company profile
- Company name
- SINTX Technologies Inc
- Ticker
- SINT.US
- Exchange
- USA Stocks
- Listed since
- Feb 13, 2014
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 32
- Fiscal year end
- December
- Address
- 1885 West 2100 South, Salt Lake City, UT, United States, 84119
- Phone
- 801 839 3500
- Website
- sintx.com
About SINTX Technologies Inc
Sintx Technologies, Inc., an advanced ceramics and biomaterials company, engages in the research, development, manufacturing, and commercialization of silicon nitride biomaterials, composites, devices, and related technologies for medical and other applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE). It also provides insulators for Tier 1 aerospace suppliers; SiNAPTIC® Foot & Ankle Osteotomy Wedge System for reconstructive surgery; OEM manufacturing of spinal implants; and SiNERGY" technology platform for bio composite and 3D printing applications. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
SINTX Technologies Inc management
5- Mr. Eric K. OlsonCEO & Chairman of the Board · born 1963
- Mr. Kevin TraskChief Financial Officer · born 1985
- Mr. Gregg Richard HonigblumChief Investment Officer & Director · born 1963
- Mr. Ryan ElmorePresident · born 1975
- Mr. Kevin J. Ontiveros Esq.Chief Legal Officer · born 1960